MRTX9768

CAS No. 2629314-68-5

MRTX9768( MRTX-9768 | MRTX9768 )

Catalog No. M28771 CAS No. 2629314-68-5

MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 642 Get Quote
10MG 1017 Get Quote
25MG 1521 Get Quote
50MG 2043 Get Quote
100MG 2673 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MRTX9768
  • Note
    Research use only, not for human use.
  • Brief Description
    MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.
  • Description
    MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.(In Vitro):MRTX-9768, a potent inhibitor of SDMA and cell proliferation in HCT116 MTAP-del cells (SDMA IC50 3 nM; prolif. IC50 11 nM) with marked selectivity over HCT116 MTAP-WT cells (SDMA IC50 544 nM; prolif. IC50 861 nM).(In Vivo):In xenograft studies, oral administration of MRTX-9768 demonstrates dose-dependent inhibition of SDMA in MTAP-del tumors, with less SDMA modulation observed in bone marrow.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MRTX-9768 | MRTX9768
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    CK2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2629314-68-5
  • Formula Weight
    424.43
  • Molecular Formula
    C24H17FN6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (117.81 mM)
  • SMILES
    FC1=C(C2=C(C3=CC=C(C(NN=C4CN)=O)C4=C3)C=NN2C)C(C#N)=C(C=CC=C5)C5=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Golub A G , Bdzhola V G , Briukhovetska N V , et al. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2[J]. European Journal of Medicinal Chemistry, 2011, 46(3):870-876.
molnova catalog
related products
  • GSK-2879552

    A potent, selective irreversible inhibitor of LSD1 with Ki app of 1.7 uM.

  • CPI-455

    A potent, specific histone demethylase pan-KDM5 inhibitor with biochemical IC50 of 10, 3 and 14 nM for KDM5A, KDM5B and KDM5C, respectively.

  • KDM4D-IN-10r

    KDM4D-IN-10r is a potent, selective histone lysine demethylase 4D (KDM4D) inhibitor with IC50 of 0.41 uM.